Albertin A, Dedola E, Bergonzi P C, Lombardo F, Fusco T, Torri G
Department of Anesthesiology, IRCCS H. San Raffaele, Vita-Salute University of Milano, Milan, Italy.
Eur J Anaesthesiol. 2006 Jun;23(6):510-6. doi: 10.1017/S0265021506000305.
The aim of this prospective, randomized, double-blind study was to determine the effects of adding two different target-controlled concentrations of remifentanil (1 and 3 ng mL(-1)) on the desflurane requirement for blunting sympathetic responses after surgical incision (minimum anaesthetic concentration (MAC(BAR)).
67 patients, aged 20-50 yr, ASA I, undergoing general anaesthesia for elective abdominal surgery were enrolled and randomly allocated to receive no remifentanil infusion (n = 21) or a target-controlled effect-site concentration of 1 ng mL(-1) (n = 24) or 3 ng mL(-1) remifentanil (n = 22). All patients were anaesthetized with propofol, cisatracurium and desflurane with a mixture of 60% nitrous oxide in oxygen. Sympathetic responses to surgical incision were determined after a 20-min period of stable end-tidal desflurane and target-controlled remifentanil concentrations. Predetermined end-tidal desflurane concentrations and the MAC(BAR) for each group were determined using an up-and-down sequential-allocation technique.
The MAC(BAR) of desflurane was higher in the group receiving no remifentanil (6.25% [95% confidence interval: 5.9-6.5%]) as compared with patients of the groups receiving 1 ng mL(-1) (2.7% [2.6-2.8%]; P < 0.001) and 3 ng mL(-1) remifentanil (2% [1.9-2.2%]; P < 0.01). When considering a MAC value in this age population and the contribution of 60% nitrous oxide (0.55 MAC), the combined MAC(BAR) values, expressed as multiples of the MAC, were 1.9, 0.8 and 0.6 MAC, in the three groups, respectively.
A target-controlled concentration of 1 ng mL(-1) remifentanil results in a 57% decrease in the MAC(BAR) of desflurane combined with 60% nitrous oxide. Increasing the target concentration of remifentanil to 3 ng mL(-1) produces a further 26% decrease in the MAC(BAR) values of desflurane.
本前瞻性、随机、双盲研究旨在确定添加两种不同目标控制浓度的瑞芬太尼(1和3 ng/mL)对手术切口后抑制交感神经反应所需地氟烷浓度(最低肺泡有效浓度[MAC(BAR)])的影响。
纳入67例年龄在20至50岁、ASA I级、接受择期腹部手术全身麻醉的患者,随机分配接受不输注瑞芬太尼(n = 21)或目标控制效应室浓度为1 ng/mL(n = 24)或3 ng/mL瑞芬太尼(n = 22)。所有患者均采用丙泊酚、顺式阿曲库铵和地氟烷进行麻醉,并吸入60%氧化亚氮和氧气的混合气体。在呼气末地氟烷和目标控制瑞芬太尼浓度稳定20分钟后,测定对手术切口的交感神经反应。使用序贯分配技术确定每组预定的呼气末地氟烷浓度和MAC(BAR)。
与接受1 ng/mL(2.7% [2.6 - 2.8%];P < 0.001)和3 ng/mL瑞芬太尼(2% [1.9 - 2.2%];P < 0.01)的患者相比,未接受瑞芬太尼的组中地氟烷的MAC(BAR)更高(6.25% [95%置信区间:5.9 - 6.5%])。考虑到该年龄人群的MAC值以及60%氧化亚氮的贡献(0.55 MAC),三组中以MAC倍数表示的联合MAC(BAR)值分别为1.9、0.8和0.6 MAC。
目标控制浓度为1 ng/mL的瑞芬太尼可使与60%氧化亚氮联合使用时地氟烷的MAC(BAR)降低57%。将瑞芬太尼的目标浓度提高到3 ng/mL可使地氟烷的MAC(BAR)值进一步降低26%。